Diligence memo · auto-generated · as of July 2, 2026
Front Range Biosciences, Inc.
Front Range Biosciences, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Front Range Biosciences, Inc. operates in Biotech / Pharma, based in LAFAYETTE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Front Range Biosciences, Inc. has raised $45M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $19M on 2020-01-31.
Most recent recorded round closed around 2020-01-31.
Valuation (modeled)modeled
Provath models Front Range Biosciences, Inc. at approximately $689M (range $38M–$2.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.35× the median modeled value of Series B Biotech / Pharma companies in 2019–2021 (11 peers) — value vs value, same stage and era. Within the normal band (135% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 9 months.
Last raise 6.4 yr ago; this sector typically re-raises about every 15 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 2.2× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 86% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 93% of those peers.
Closest niche peers: Mantra Bio, Inc., Nido Biosciences, Inc., LifeVault Bio, Inc., Pharmajet, Inc., Paragon Biosciences CIRC Holdings, LLC.
Peoplefiled
8 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.